PDL BioPharma up for sale

PDL BioPharma Inc. (PDL) is actively seeking offers for the sale of the company as a whole or of its key assets following a review of its strategic alternatives.

In conjunction with the announcement of the potential sale on Monday, CEO and director Mark McDade also stepped down immediately. The company’s board elected former chairperson of the board L. Patrick Gage as interim CEO and Karen A. Dawes as the new chairperson of the board.

The company has said it is relocating from Fremont to Redwood City this fall.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

New audio of couple calling police on SF man bolsters racial bias claims, supe says

Pacific Heights incident spurred CAREN Act to outlaw discriminatory reports to police

SFUSD students may start the school year at home

Staff report recommends starting with distance learning in the fall, transitioning to hybrid model

Universities fight new immigration restrictions on international students in court

Local colleges are scrambling to keep international students in the country as… Continue reading

SF library plans to reopen with pickup and drop-off services

Since March, all 28 library locations in San Francisco have been closed… Continue reading

California releasing most prison inmates 12 weeks early to clear space amid coronavirus

California prisons will release inmates as early as 12 weeks ahead of… Continue reading

Most Read